Skip to main content
logo
TransMedics Group, Inc. (BIT:1TMDX)
Italy flag Italy · Delayed Price · Currency is EUR
106.20
+0.55 (0.52%)
At close: Mar 13, 2026

TransMedics Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
190.2935.46-25.03-36.23-44.22
Depreciation & Amortization
27.1919.768.183.481.82
Stock-Based Compensation
36.8633.2219.7910.326.88
Other Adjustments
-79.875.3628.383.373.65
Change in Receivables
13.95-34.31-33.82-21.680.84
Changes in Inventories
-7.72-8.35-28.09-8.02-4.89
Changes in Accounts Payable
-0.02-1.46.96-3.275.09
Changes in Accrued Expenses
17.697.9414.253.444.88
Changes in Unearned Revenue
1.14-0.20.08-0.01
Changes in Other Operating Activities
-6.68-8.68-3.732.78-2.92
Operating Cash Flow
192.8448.8-13.03-45.82-28.86
Operating Cash Flow Growth
295.14%----
Capital Expenditures
-59.25-129.74-151.85-11.91-3.52
Purchases of Intangible Assets
---27.21--
Purchases of Investments
----10.5-72.02
Proceeds from Sale of Investments
---76.92104.81
Payments for Business Acquisitions
-0.44-14.89--
Investing Cash Flow
-59.25-129.3-193.9554.5129.27
Long-Term Debt Issued
--445.3858.51-
Long-Term Debt Repaid
----36.05-
Net Long-Term Debt Issued (Repaid)
--445.3822.46-
Issuance of Common Stock
1722.877.11145.471.39
Repurchase of Common Stock
-0.14----
Net Common Stock Issued (Repurchased)
16.8622.877.11145.471.39
Other Financing Activities
---52.07--
Financing Cash Flow
16.8622.87400.42167.931.39
Effect of Exchange Rate Changes on Cash and Cash Equivalents
1.27-0.540.19-1.02-0.8
Net Cash Flow
151.72-58.16193.63175.61
Free Cash Flow
133.59-80.94-164.88-57.72-32.38
FCF Margin
22.06%-18.33%-68.24%-61.76%-107.01%
Free Cash Flow Per Share
3.30-2.30-5.07-1.95-1.17
Levered Free Cash Flow
162.65-85.21266.15-27.28-43.75
Unlevered Free Cash Flow
-2.64-82.85-184.7-44.89-38.93
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.